Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Altered temporal sensitivity in obesity is linked to pro-inflammatory state.

Scarpina F, Marzullo P, Mai S, Mauro A, Scacchi M, Costantini M.

Sci Rep. 2019 Oct 29;9(1):15508. doi: 10.1038/s41598-019-51660-5.


Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity.

Pucci M, Micioni Di Bonaventura MV, Vezzoli V, Zaplatic E, Massimini M, Mai S, Sartorio A, Scacchi M, Persani L, Maccarrone M, Cifani C, D'Addario C.

Front Genet. 2019 Jun 14;10:523. doi: 10.3389/fgene.2019.00523. eCollection 2019.


Circulating adipokines and metabolic setting in differentiated thyroid cancer.

Mele C, Samà MT, Bisoffi AA, Caputo M, Bullara V, Mai S, Walker GE, Prodam F, Marzullo P, Aimaretti G, Pagano L.

Endocr Connect. 2019 Jun 1. pii: EC-19-0262. doi: 10.1530/EC-19-0262. [Epub ahead of print]


Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables.

Maestrini S, Mele C, Mai S, Vietti R, Di Blasio A, Castello L, Surico D, Aimaretti G, Scacchi M, Marzullo P.

Obes Facts. 2018;11(5):429-439. doi: 10.1159/000492001. Epub 2018 Oct 30.


Analysis of Predictive Equations for Estimating Resting Energy Expenditure in a Large Cohort of Morbidly Obese Patients.

Cancello R, Soranna D, Brunani A, Scacchi M, Tagliaferri A, Mai S, Marzullo P, Zambon A, Invitti C.

Front Endocrinol (Lausanne). 2018 Jul 25;9:367. doi: 10.3389/fendo.2018.00367. eCollection 2018.


Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines.

Gilardini L, Lombardi C, Redaelli G, Mattaliano P, Fanari P, Cornacchia M, Scacchi M, Mai S, Ferronato P, Parati G, Invitti C.

J Hypertens. 2018 Jan;36(1):199-204. doi: 10.1097/HJH.0000000000001507.


Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome.

Mele C, Grugni G, Mai S, Vietti R, Aimaretti G, Scacchi M, Marzullo P.

Sci Rep. 2017 Jun 9;7(1):3186. doi: 10.1038/s41598-017-03538-7.


Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin.

Mai S, Walker GE, Vietti R, Cattaldo S, Mele C, Priano L, Mauro A, Bona G, Aimaretti G, Scacchi M, Marzullo P.

Nutrients. 2017 May 5;9(5). pii: E459. doi: 10.3390/nu9050459.


The impact of the metabolic phenotype on thyroid function in obesity.

Marzullo P, Mele C, Mai S, Guzzaloni G, Soranna D, Tagliaferri MA, Berselli ME, Prodam F, Surico D, Aimaretti G, Scacchi M.

Diabetol Metab Syndr. 2016 Aug 24;8(1):59. doi: 10.1186/s13098-016-0177-x. eCollection 2016.


Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity.

Mai S, Walker GE, Brunani A, Guzzaloni G, Grossi G, Oldani A, Aimaretti G, Scacchi M, Marzullo P.

Sci Rep. 2014 Jul 24;4:5803. doi: 10.1038/srep05803.


GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies.

Limonta P, Montagnani Marelli M, Mai S, Motta M, Martini L, Moretti RM.

Endocr Rev. 2012 Oct;33(5):784-811. doi: 10.1210/er.2012-1014. Epub 2012 Jul 9. Review.


Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells.

Moretti RM, Mai S, Montagnani Marelli M, Rizzi F, Bettuzzi S, Limonta P.

Int J Oncol. 2011 Jul;39(1):225-34. doi: 10.3892/ijo.2011.1030. Epub 2011 May 3.


Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.

Moretti RM, Mai S, Montagnani Marelli M, Bani MR, Ghilardi C, Giavazzi R, Taylor DM, Martini PG, Limonta P.

Endocrinology. 2010 Oct;151(10):4643-53. doi: 10.1210/en.2010-0163. Epub 2010 Aug 4.


Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation.

Montagnani Marelli M, Moretti RM, Mai S, Müller O, Van Groeninghen JC, Limonta P.

Oncol Rep. 2009 May;21(5):1277-82.


Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.

Montagnani Marelli M, Moretti RM, Mai S, Januszkiewicz-Caulier J, Motta M, Limonta P.

J Clin Endocrinol Metab. 2009 May;94(5):1761-7. doi: 10.1210/jc.2008-1741. Epub 2009 Feb 3.


Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.

Moretti RM, Montagnani Marelli M, Mai S, Cariboni A, Scaltriti M, Bettuzzi S, Limonta P.

Cancer Res. 2007 Nov 1;67(21):10325-33.


Supplemental Content

Loading ...
Support Center